Certara, Inc. — Investor Relations & Filings
Certara, Inc. is a company that accelerates drug discovery and development through the use of proprietary biosimulation software, technology, and expert services. It provides an end-to-end platform that supports clients across the entire drug development lifecycle, from discovery and preclinical research to clinical trials, regulatory submissions, and market access. The company's solutions leverage predictive simulation, data-driven modeling, and advanced analytics to help pharmaceutical and biotechnology organizations optimize trial design, justify dosing decisions, and navigate regulatory requirements. Key software products include Simcyp, Phoenix, and Pinnacle 21. Certara's offerings are designed to de-risk development, enhance efficiency, and increase the likelihood of bringing new medicines to patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-15 | English | |
| 10-Q - Certara, Inc. (0001827090) (Filer) | 2026-05-11 | English | |
| 8-K - Certara, Inc. (0001827090) (Filer) | 2026-05-11 | English | |
| 8-K - Certara, Inc. (0001827090) (Filer) | 2026-04-22 | English | |
| ARS - Certara, Inc. (0001827090) (Filer) | 2026-04-03 | English | |
| DEF 14A - Certara, Inc. (0001827090) (Filer) | 2026-04-03 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 46362687 | FORM 8-K | 2026-05-15 | English | ||
| 44937560 | 10-Q - Certara, Inc. (0001827090) (Filer) | 2026-05-11 | English | ||
| 44936931 | 8-K - Certara, Inc. (0001827090) (Filer) | 2026-05-11 | English | ||
| 35223149 | 8-K - Certara, Inc. (0001827090) (Filer) | 2026-04-22 | English | ||
| 33256151 | ARS - Certara, Inc. (0001827090) (Filer) | 2026-04-03 | English | ||
| 33255090 | DEF 14A - Certara, Inc. (0001827090) (Filer) | 2026-04-03 | English | ||
| 32899219 | 4 - CERTARA, INC. (0001827090) (Filer) | 2026-03-02 | English | ||
| 32899221 | 10-K - CERTARA, INC. (0001827090) (Filer) | 2026-02-26 | English | ||
| 32899220 | 8-K - CERTARA, INC. (0001827090) (Filer) | 2026-02-26 | English | ||
| 13319431 | Director's Dealing 2026 | 2026-01-12 | English | ||
|
2025
5 filings
| |||||
| 13319432 | FORM 8-K | 2025-12-11 | English | ||
| 13319433 | Major Shareholding Notification 2025 | 2025-11-25 | English | ||
| 13319434 | Major Shareholding Notification 2025 | 2025-11-13 | English | ||
| 13319435 | Director's Dealing 2025 | 2025-11-12 | English | ||
| 13319436 | 10-Q | 2025-11-06 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
SLSBio(Specialty Lab Solution Bio) Co., Ltd
Offers lab services and manufactures diagnostics for the ph…
|
246250 | KR | Professional, scientific and te… |
|
SMO ClinPlus CO., LTD.
Provides clinical trial site management, CRC services, and …
|
301257 | CN | Professional, scientific and te… |
|
Soiken Holdings Inc.
Commercializes medical research via biomarker tech, clinica…
|
2385 | JP | Professional, scientific and te… |
|
Solid Biosciences Inc.
Develops gene therapies for rare neuromuscular and cardiac …
|
SLDB | US | Professional, scientific and te… |
|
Sona Nanotech Inc.
Develops and supplies proprietary gold nanorod technology f…
|
SONA | CA | Professional, scientific and te… |
|
SPARC TECHNOLOGIES LIMITED
Develops graphene technologies, green hydrogen, and sodium-…
|
SPN | AU | Professional, scientific and te… |
|
SpectraCure
Develops a minimally invasive treatment system for internal…
|
SPEC | SE | Professional, scientific and te… |
|
Sprint Bioscience
Develops and out-licenses preclinical oncology drug candida…
|
SPRINT | SE | Professional, scientific and te… |
|
SPRUCE BIOSCIENCES, INC.
A clinical-stage biopharma developing therapies for underse…
|
SPRB | US | Professional, scientific and te… |
|
SpyGlass Pharma, Inc.
Ophthalmic biotech developing drug delivery integrated with…
|
SGP | US | Professional, scientific and te… |
Certara, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31699/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31699 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31699 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31699 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31699}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Certara, Inc. (id: 31699)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.